You are viewing the site in preview mode

Skip to main content

Table 7 Proviral load for each HLA-B allele and clinical status

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

Allele Population Mean PVL
AC ATLL HAM
HLA-B*07 11.83* – – 11.83
HLA-B*08 0.39* – 15.12 10.21
HLA-B*13 – – 35.1* 35.1
HLA-B*14 5.3* 1.3* 3.58** 3.44
HLA-B*15 – – 3.07** 3.07
HLA-B*18 – 0.82** – 0.81
HLA-B*35 – 5.1** 6.44 6.12
HLA-B*38 2.1** – – 2.1
HLA-B*39 0.24 18.78 7.84 10.36
HLA-B*41 – – ND ND
HLA-B*44 0.58* 33.98* 29.54* 21.36
HLA-B*48 1.24 – – 1.24
HLA-B*49 – – 35.1* 35.1
HLA-B*51 0.74 12.49* 3.7 4.11
HLA-B*52 0.57* – 9.32** 6.41
HLA-B*53 3.42 – – 3.42
HLA-B*55 – – 4.03* 4.03
  1. AC asymptomatics carriers, HAM HTLV-1 associated myelopathy, ATLL Adult T cell leukemia/lymphoma, NII Non-infected Individuals, HLA Human leukocyte antigen, PVL proviral load
  2. *Only the PVL of one allele was available, **Mean PVL of two alleles
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us